Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1993 Mar;69(3):223–227. doi: 10.1136/hrt.69.3.223

Lack of rebound during intermittent transdermal treatment with glyceryl trinitrate in patients with stable angina on background beta blocker.

D R Holdright 1, R J Katz 1, C A Wright 1, J L Sparrow 1, A K Sullivan 1, A D Cunningham 1, K M Fox 1
PMCID: PMC1024984  PMID: 8096389

Abstract

OBJECTIVE--To assess whether intermittent transdermal treatment with glyceryl trinitrate causes clinically significant rebound in patients maintained on beta blockers for stable angina pectoris. DESIGN--Serial treadmill exercise testing in a double blind, randomised, placebo controlled cross over trial. Baseline exercise testing was performed at 0900 and 1100 at visit 1. Transdermal glyceryl trinitrate patches releasing 15 mg/24 h were applied at 2200 the evening before visits 2 and 3, and exercise testing was performed at 0900 the next morning. The patch was removed and replaced with either an identical patch or matching placebo and exercise tests were repeated two hours later. The alternative treatment was given at visit 3. SETTING--Tertiary referral centre. PATIENTS--14 patients with stable angina pectoris maintained on beta blocker treatment alone. MAIN OUTCOME MEASURES--Time to angina, 1 mm ST segment depression, and total time, together with heart rate, systolic blood pressure, and rate-pressure product. RESULTS--Active treatment improved treadmill performance at 0900 and 1100. Time to angina, time to 1 mm ST segment depression, and total time fell significantly on placebo compared with the 0900 exercise test on active treatment, but were not significantly different to the baseline exercise test either. CONCLUSIONS--Intermittent transdermal treatment with glyceryl trinitrate is not associated with the rebound phenomenon in patients maintained on beta blockers for stable angina pectoris.

Full text

PDF
223

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Colditz G. A., Halvorsen K. T., Goldhaber S. Z. Randomized clinical trials of transdermal nitroglycerin systems for the treatment of angina: a meta-analysis. Am Heart J. 1988 Jul;116(1 Pt 1):174–180. doi: 10.1016/0002-8703(88)90263-3. [DOI] [PubMed] [Google Scholar]
  2. Cowan J. C., Bourke J. P., Reid D. S., Julian D. G. Prevention of tolerance to nitroglycerin patches by overnight removal. Am J Cardiol. 1987 Aug 1;60(4):271–275. doi: 10.1016/0002-9149(87)90226-8. [DOI] [PubMed] [Google Scholar]
  3. Crean P. A., Ribeiro P., Crea F., Davies G. J., Ratcliffe D., Maseri A. Failure of transdermal nitroglycerin to improve chronic stable angina: a randomized, placebo-controlled, double-blind, double crossover trial. Am Heart J. 1984 Dec;108(6):1494–1500. doi: 10.1016/0002-8703(84)90697-5. [DOI] [PubMed] [Google Scholar]
  4. DeMots H., Glasser S. P. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina. J Am Coll Cardiol. 1989 Mar 15;13(4):786–795. doi: 10.1016/0735-1097(89)90216-7. [DOI] [PubMed] [Google Scholar]
  5. Dupuis J., Lalonde G., Lemieux R., Rouleau J. L. Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine. J Am Coll Cardiol. 1990 Oct;16(4):923–931. doi: 10.1016/s0735-1097(10)80342-0. [DOI] [PubMed] [Google Scholar]
  6. Ferratini M., Pirelli S., Merlini P., Silva P., Pollavini G. Intermittent transdermal nitroglycerin monotherapy in stable exercise-induced angina: a comparison with a continuous schedule. Eur Heart J. 1989 Nov;10(11):998–1002. doi: 10.1093/oxfordjournals.eurheartj.a059425. [DOI] [PubMed] [Google Scholar]
  7. Fox K. M., Dargie H. J., Deanfield J., Maseri A. Avoidance of tolerance and lack of rebound with intermittent dose titrated transdermal glyceryl trinitrate. The Transdermal Nitrate Investigators. Br Heart J. 1991 Aug;66(2):151–155. doi: 10.1136/hrt.66.2.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gumbrielle T., Freedman S. B., Fogarty L., Ogasawara S., Sobb P., Kelly D. T. Efficacy, safety and duration of nitrate-free interval to prevent tolerance to transdermal nitroglycerin in effort angina. Eur Heart J. 1992 May;13(5):671–678. doi: 10.1093/oxfordjournals.eurheartj.a060234. [DOI] [PubMed] [Google Scholar]
  9. Lange R. L., Reid M. S., Tresch D. D., Keelan M. H., Bernhard V. M., Coolidge G. Nonatheromatous ischemic heart disease following withdrawal from chronic industrial nitroglycerin exposure. Circulation. 1972 Oct;46(4):666–678. doi: 10.1161/01.cir.46.4.666. [DOI] [PubMed] [Google Scholar]
  10. Luke R., Sharpe N., Coxon R. Transdermal nitroglycerin in angina pectoris: efficacy of intermittent application. J Am Coll Cardiol. 1987 Sep;10(3):642–646. doi: 10.1016/s0735-1097(87)80208-5. [DOI] [PubMed] [Google Scholar]
  11. Muller J. E., Gunther S. J. Nifedipine therapy for Prinzmetal's angina. Circulation. 1978 Jan;57(1):137–139. doi: 10.1161/01.cir.57.1.137. [DOI] [PubMed] [Google Scholar]
  12. Müller P., Imhof P. R., Burkart F., Chu L. C., Gérardin A. Human pharmacological studies of a new transdermal system containing nitroglycerin. Eur J Clin Pharmacol. 1982;22(6):473–480. doi: 10.1007/BF00609617. [DOI] [PubMed] [Google Scholar]
  13. Packer M. What causes tolerance to nitroglycerin? The 100 year old mystery continues. J Am Coll Cardiol. 1990 Oct;16(4):932–935. doi: 10.1016/s0735-1097(10)80343-2. [DOI] [PubMed] [Google Scholar]
  14. Parker J. O., Fung H. L. Transdermal nitroglycerin in angina pectoris. Am J Cardiol. 1984 Sep 1;54(6):471–476. doi: 10.1016/0002-9149(84)90233-9. [DOI] [PubMed] [Google Scholar]
  15. Reeves W. C., Cook L., Wood M. A., Whitesell L. Coronary artery spasm after abrupt withdrawal of nitroglycerin in rabbits. Am J Cardiol. 1985 Apr 1;55(8):1066–1069. doi: 10.1016/0002-9149(85)90748-9. [DOI] [PubMed] [Google Scholar]
  16. Schaer D. H., Buff L. A., Katz R. J. Sustained antianginal efficacy of transdermal nitroglycerin patches using an overnight 10-hour nitrate-free interval. Am J Cardiol. 1988 Jan 1;61(1):46–50. doi: 10.1016/0002-9149(88)91302-1. [DOI] [PubMed] [Google Scholar]
  17. Sullivan M., Savvides M., Abouantoun S., Madsen E. B., Froelicher V. Failure of transdermal nitroglycerin to improve exercise capacity in patients with angina pectoris. J Am Coll Cardiol. 1985 May;5(5):1220–1223. doi: 10.1016/s0735-1097(85)80028-0. [DOI] [PubMed] [Google Scholar]
  18. Thadani U., Hamilton S. F., Olson E., Anderson J., Voyles W., Prasad R., Teague S. M. Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance. Ann Intern Med. 1986 Oct;105(4):485–492. doi: 10.7326/0003-4819-105-4-485. [DOI] [PubMed] [Google Scholar]
  19. Waters D. D., Juneau M., Gossard D., Choquette G., Brien M. Limited usefulness of intermittent nitroglycerin patches in stable angina. J Am Coll Cardiol. 1989 Feb;13(2):421–425. doi: 10.1016/0735-1097(89)90521-4. [DOI] [PubMed] [Google Scholar]
  20. de Milliano P. A., Koster R. W., Bär F. W., Janssen J., de Cock C., Schelling A., van de Bos A. Long-term efficacy of continuous and intermittent use of transdermal nitroglycerin in stable angina pectoris. Am J Cardiol. 1991 Oct 1;68(9):857–862. doi: 10.1016/0002-9149(91)90399-6. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES